NCT03842449

Brief Summary

France is the country of Europe where the prevalence of pregnant women smokers is the highest (35.9% before pregnancy and in the 3rd quarter 21.8% in 2008). In the investigator's country, among the smokers of early pregnancy with the usual care, only 30% manage to stop during pregnancy. Maternal smoking during pregnancy is a clearly identified risk factor for the course of pregnancy and the unborn child. The measurement of carbon monoxide (CO) expired in pregnancy monitoring consultation is part of the recommendations of the consensus conference "Pregnancy and Tobacco" (ANAES, October 2004) and the parliamentary report on smoking by JL Touraine and D. Jacquat (Feb 2012). However, this recommendation has not entered the current practice. The research aims to justify the clinical relevance of this recommendation by demonstrating the positive impact of expired CO measurement on the rate of discontinuation during pregnancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2019

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 18, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2022

Completed
Last Updated

March 17, 2021

Status Verified

March 1, 2021

Enrollment Period

3 years

First QC Date

January 25, 2019

Last Update Submit

March 16, 2021

Conditions

Keywords

TobaccoPregnancy AddictivePregnant WomenStop smoking

Outcome Measures

Primary Outcomes (1)

  • Smoking cessation on the date of birth

    Evaluate the impact on maternal smoking cessation rate at birth of a strategy combining maternal expired CO measurement, restitution, and outcome comment initiated no later than at the 24th week of amenorrhea and conducted thoughout the whole pregnancy.

    Date of birth

Secondary Outcomes (5)

  • Impact on maternal, placental and fetal exposure to the toxic and compounds of tobacco smoke.

    Date of birth

  • Impact on the intention of breastfeeding on the date of birth

    Date of birth

  • Predictive value of expired CO in relation to maternal-fetal exposure to these toxic and compounds

    Date of birth

  • Maternal expired CO on the day of birth

    Date of birth

  • Determinants of smoking cessation on the day of birth

    Date of birth

Study Arms (3)

Smoking pregnant woman withCO measurement

EXPERIMENTAL
Diagnostic Test: BabyCOOther: Biological samples

Smoking pregnant woman without CO measurement

OTHER
Other: Biological samples

Non Smoking pregnant woman

OTHER
Other: Biological samples

Interventions

BabyCODIAGNOSTIC_TEST

An expired CO measurement will be performed by BabyCO and the result will be returned to the smoking pregnant woman by the consultant.

Smoking pregnant woman withCO measurement

The nature of the samples taken during the delivery are: * maternal blood, * cord blood * placenta fragment

Non Smoking pregnant womanSmoking pregnant woman withCO measurementSmoking pregnant woman without CO measurement

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Group of smoking pregnant women (N = 600):
  • Pregnant women declaring themselves smokers (at least one cigarette a day).
  • Aged at least 18 years old.
  • Consultant at Limoges University Hospital before the 24th week of amenorrhea.
  • Desiring to be followed for their entire pregnancy at the Children's.
  • Desiring to give birth at the Children's.
  • Accepting to participate in the study
  • Group of strictly non-smoking pregnant women (N = 50):
  • Pregnant women :
  • Declaring not to be a smoker (to have been totally weaned for more than one year and to have smoked less than 100 cigarettes in her lifetime) before the beginning of the current pregnancy, and
  • Whose partner and family do not smoke, and
  • Not significantly exposed to tobacco (in their professional environment in particular), and
  • With a CO measurement expired \<3 ppm.
  • Aged at least 18 years old.
  • Consultant at Limoges University Hospital before the 24th SA.
  • +2 more criteria

You may not qualify if:

  • Group of smoking pregnant women (N = 600) :
  • Women with the following social and / or legal criteria: guardianship, curatorship, safeguard of justice.
  • Women unable to understand the objectives of the study and the constraints of the protocol.
  • Group of strictly non-smoking pregnant women (N = 50) :
  • Women with the following social and / or legal criteria: guardianship, curatorship, safeguard of justice.
  • Women unable to understand the objectives of the study and the constraints of the protocol.
  • Women with high blood pressure
  • Diabetic woman
  • Woman with hypothyroidism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Limoges

Limoges, 87042, France

Location

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2019

First Posted

February 15, 2019

Study Start

March 18, 2019

Primary Completion

March 18, 2022

Study Completion

March 18, 2022

Last Updated

March 17, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations